Home / Technical Content / Improving siRNA Production Efficiency

White paper

Improving siRNA Production Efficiency

With engineered double-stranded RNA (dsRNA) ligases

Demand for oligonucleotide therapeutics, such as small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), has skyrocketed as their use has expanded to encompass larger disease indications. This exciting shift in the industry creates the need for enhanced manufacturing technologies.

In this paper, we showcase how engineered double-stranded RNA (dsRNA) ligases, designed for ligation of RNA fragments as a novel synthesis approach to improve siRNA production efficiency.

Engineered dsRNA ligases can efficiently scale siRNA manufacturing through:

  • Faster process development
  • Improved manufacturability
  • Custom pharma manufacturing expertise
  • Higher scalability
  • Complements solid state synthesis

See how by downloading this white paper.

Gated content

Please complete the form below to access this content.

Discover the Expertise Powering Possibility

Speak to our experts to learn how our platforms deliver smarter science, faster timelines, and greater confidence. Let’s talk.

graphic

Related content

Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis

TIDES USA 2025: Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis

TIDES USA 2025: Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: Phosphoramidite Chemistry vs Enzymatic Synthesis

Want to see more technical content?

graphic

We're Paving Your Path to the Future

You own the product and we own the path. Together, we’ll take it to market clearly, cleanly and without surprises.

graphic